Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Increase the proportion of oral and pharyngeal cancers detected at the earliest stage — OH‑07 Data Methodology and Measurement

On this page:  About this objective  |  Methodology  |  History

About this objective

Data

Data Source:  Surveillance, Epidemiology, and End Results Program (SEER), NIH/NCI

National baseline: 29.5 percent of oral and pharyngeal cancers were detected at the earliest stage (Stage 1 localized) in 2016

National target: 34.2 percent

Numerator
Number of incident cancer cases in localized stage of the oral cavity and pharynx (ICD-10 codes C00-C14).
Denominator
Number of diagnosed incident cancer case of the oral cavity and pharynx (ICD-10 codes C00-C14).
National target-setting method
Percentage point improvement
National target-setting method details
Percentage point improvement from the baseline using Cohen's h effect size of 0.10.
1
National target-setting method justification
Trend data were not available for this objective. A percentage point improvement was calculated using Cohen's h effect size of 0.1. This method was used because no additional information could be used to assess the target.

Methodology

Methodology notes

The data source is the United States Cancer Statistics (USCS) report which uses the combined data from the NCI Surveillance, Epidemiology and End Results (SEER) registry data and the CDC National Program of Cancer Registries. Together, these registries cover more than 96% of the U.S. population.

History

Comparable HP2020 objective
Retained, which includes core objectives that are continuing from Healthy People 2020 with no change in measurement.

1. Effect size h=0.1 was chosen to correspond with 10% improvement from a baseline of 50%.